Interaction of Opioids with TLR4—Mechanisms and Ramifications
The innate immune receptor toll-like receptor 4 (TLR4) is known as a sensor for the gram-negative bacterial cell wall component lipopolysaccharide (LPS). TLR4 activation leads to a strong pro-inflammatory response in macrophages; however, it is also recognised to play a key role in cancer. Recent st...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/143acb6bbf5b4985a371157f0e1aa57e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:143acb6bbf5b4985a371157f0e1aa57e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:143acb6bbf5b4985a371157f0e1aa57e2021-11-11T15:26:57ZInteraction of Opioids with TLR4—Mechanisms and Ramifications10.3390/cancers132152742072-6694https://doaj.org/article/143acb6bbf5b4985a371157f0e1aa57e2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5274https://doaj.org/toc/2072-6694The innate immune receptor toll-like receptor 4 (TLR4) is known as a sensor for the gram-negative bacterial cell wall component lipopolysaccharide (LPS). TLR4 activation leads to a strong pro-inflammatory response in macrophages; however, it is also recognised to play a key role in cancer. Recent studies of the opioid receptor (OR)-independent actions of opioids have identified that TLR4 can respond to opioids. Opioids are reported to weakly activate TLR4, but to significantly inhibit LPS-induced TLR4 activation. The action of opioids at TLR4 is suggested to be non-stereoselective, this is because OR-inactive (+)-isomers of opioids have been shown to activate or to inhibit TLR4 signalling, although there is some controversy in the literature. While some opioids can bind to the lipopolysaccharide (LPS)-binding cleft of the Myeloid Differentiation factor 2 (MD-2) co-receptor, pharmacological characterisation of the inhibition of opioids on LPS activation of TLR4 indicates a noncompetitive mechanism. In addition to a direct interaction at the receptor, opioids affect NF-κB activation downstream of both TLR4 and opioid receptors and modulate TLR4 expression, leading to a range of in vivo outcomes. Here, we review the literature reporting the activity of opioids at TLR4, its proposed mechanism(s), and the complex functional consequences of this interaction.Mai Mahmoud GabrIqira SaeedJared A. MilesBenjamin P. RossPaul Nicholas ShawMarkus W. HollmannMarie-Odile ParatMDPI AGarticletoll-like receptor 4morphineopioidslipopolysaccharideNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5274, p 5274 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
toll-like receptor 4 morphine opioids lipopolysaccharide Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
toll-like receptor 4 morphine opioids lipopolysaccharide Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Mai Mahmoud Gabr Iqira Saeed Jared A. Miles Benjamin P. Ross Paul Nicholas Shaw Markus W. Hollmann Marie-Odile Parat Interaction of Opioids with TLR4—Mechanisms and Ramifications |
description |
The innate immune receptor toll-like receptor 4 (TLR4) is known as a sensor for the gram-negative bacterial cell wall component lipopolysaccharide (LPS). TLR4 activation leads to a strong pro-inflammatory response in macrophages; however, it is also recognised to play a key role in cancer. Recent studies of the opioid receptor (OR)-independent actions of opioids have identified that TLR4 can respond to opioids. Opioids are reported to weakly activate TLR4, but to significantly inhibit LPS-induced TLR4 activation. The action of opioids at TLR4 is suggested to be non-stereoselective, this is because OR-inactive (+)-isomers of opioids have been shown to activate or to inhibit TLR4 signalling, although there is some controversy in the literature. While some opioids can bind to the lipopolysaccharide (LPS)-binding cleft of the Myeloid Differentiation factor 2 (MD-2) co-receptor, pharmacological characterisation of the inhibition of opioids on LPS activation of TLR4 indicates a noncompetitive mechanism. In addition to a direct interaction at the receptor, opioids affect NF-κB activation downstream of both TLR4 and opioid receptors and modulate TLR4 expression, leading to a range of in vivo outcomes. Here, we review the literature reporting the activity of opioids at TLR4, its proposed mechanism(s), and the complex functional consequences of this interaction. |
format |
article |
author |
Mai Mahmoud Gabr Iqira Saeed Jared A. Miles Benjamin P. Ross Paul Nicholas Shaw Markus W. Hollmann Marie-Odile Parat |
author_facet |
Mai Mahmoud Gabr Iqira Saeed Jared A. Miles Benjamin P. Ross Paul Nicholas Shaw Markus W. Hollmann Marie-Odile Parat |
author_sort |
Mai Mahmoud Gabr |
title |
Interaction of Opioids with TLR4—Mechanisms and Ramifications |
title_short |
Interaction of Opioids with TLR4—Mechanisms and Ramifications |
title_full |
Interaction of Opioids with TLR4—Mechanisms and Ramifications |
title_fullStr |
Interaction of Opioids with TLR4—Mechanisms and Ramifications |
title_full_unstemmed |
Interaction of Opioids with TLR4—Mechanisms and Ramifications |
title_sort |
interaction of opioids with tlr4—mechanisms and ramifications |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/143acb6bbf5b4985a371157f0e1aa57e |
work_keys_str_mv |
AT maimahmoudgabr interactionofopioidswithtlr4mechanismsandramifications AT iqirasaeed interactionofopioidswithtlr4mechanismsandramifications AT jaredamiles interactionofopioidswithtlr4mechanismsandramifications AT benjaminpross interactionofopioidswithtlr4mechanismsandramifications AT paulnicholasshaw interactionofopioidswithtlr4mechanismsandramifications AT markuswhollmann interactionofopioidswithtlr4mechanismsandramifications AT marieodileparat interactionofopioidswithtlr4mechanismsandramifications |
_version_ |
1718435290229506048 |